Buy KPV — USA-Made, COA per Lot
High-purity KPV (Lysine-Proline-Valine) tripeptide is essential for researchers investigating cytokine signaling, mucosal immunity, and epithelial barrier function. PX1 Research provides USA-synthesized, HPLC/MS-verified KPV with lot-specific Certificates of Analysis and rigorous endotoxin screening to ensure reproducible experimental results.
Quick answer
High-purity KPV (Lysine-Proline-Valine) tripeptide is essential for researchers investigating cytokine signaling, mucosal immunity, and epithelial barrier function. PX1 Research provides USA-synthesized, HPLC/MS-verified KPV with lot-specific Certificates of Analysis and rigorous endotoxin screening to ensure reproducible experimental results.
Key takeaways
- [KPV](/research-peptides/kpv) is a tripeptide sequence consisting of Lysine-Proline-Valine derived from the C-terminal fragment of alpha-Melanocyte-Stimulating Hormone (alpha-MSH).
- The primary primary sequence of [KPV](/research-peptides/kpv) (Lys-Pro-Val) dictates its structural stability and specific biochemical interaction profile.
- A major area of focus for investigators purchasing [KPV](/research-peptides/kpv) centers on gastrointestinal mucosal biology.
- When designing protocols for mucosal preservation or systemic inflammation, researchers often compare [KPV](/research-peptides/kpv) with other prominent agents in the class.
Introduction to KPV (Lysine-Proline-Valine) in Biochemical Research
KPV is a tripeptide sequence consisting of Lysine-Proline-Valine derived from the C-terminal fragment of alpha-Melanocyte-Stimulating Hormone (alpha-MSH). In preclinical research, alpha-MSH derivative peptides have garnered significant interest due to their capacity to modulate inflammatory cascades without exhibiting systemic endocrine toxicity. When investigators evaluate options to buy KPV, ensuring molecular purity and batch consistency is paramount to obtaining reliable quantitative data.
Unlike full-length neuropeptides, KPV retains the core anti-inflammatory properties of alpha-MSH while possessing a vastly reduced molecular weight (383.48 g/mol). This compact molecular architecture facilitates cellular uptake and stability across diverse in vitro assays and animal models. Laboratories across the United States utilize this research compound to evaluate localized cellular responses, cellular transport dynamics, and signaling inhibition.
Molecular Structure and Receptor-Independent Signaling Pathways
The primary primary sequence of KPV (Lys-Pro-Val) dictates its structural stability and specific biochemical interaction profile. While alpha-MSH acts predominantly through melanocortin receptors (MC1R through MC5R), preclinical evidence indicates that KPV can exert physiological effects via both receptor-dependent and receptor-independent mechanisms. This dual operational mode makes it a uniquely versatile tool in anti-inflammatory peptides research.
In vitro data demonstrate that KPV enters the cytoplasm via specific peptide transporters, such as PepT1 (SLC15A1), which is prominently expressed in intestinal epithelial cells. Once intracellular, KPV interacts directly with nuclear factor kappa B (NF-κB) signaling pathways. By attenuating NF-κB translocation to the nucleus, KPV reduces the transcriptional activation of key pro-inflammatory cytokines, including TNF-α, IL-1β, and IL-6. Understanding these baseline biochemical dynamics allows researchers to isolate specific signaling nodes in controlled assays.
Preclinical Research Applications: Intestinal Barrier Integrity and Colitis Models
A major area of focus for investigators purchasing KPV centers on gastrointestinal mucosal biology. Preclinical studies suggest that KPV plays a significant role in maintaining mucosal barrier integrity, modulating tight junction protein expression, and dampening luminal inflammatory cascades. In murine models of chemical-induced colitis (such as DSS or TNBS models), administration of KPV has been shown to reduce mucosal damage, decrease histological inflammation scores, and restore normal epithelial architecture.
Furthermore, in vitro research utilizing Caco-2 and HT-29 monolayer cultures demonstrates that KPV counteracts cytokine-induced disruption of zonula occludens-1 (ZO-1) and occludin. By preserving these tight junction frameworks, KPV helps prevent transepithelial electrical resistance (TEER) degradation. Researchers exploring inflammatory bowel disease (IBD) pathways utilize high-grade KPV to study these repair kinetics without the confounding variables introduced by unrefined or impure peptide mixtures.
Comparative Analysis: KPV and Related Barrier-Modulating Research Peptides
When designing protocols for mucosal preservation or systemic inflammation, researchers often compare KPV with other prominent agents in the class. For instance, BPC-157 is widely studied for tissue regeneration and angiogenic modulation, operating through nitric oxide pathways and growth factor upregulation. In contrast, KPV works primarily through targeted intracellular NF-κB suppression and PepT1-mediated transport.
Similarly, research compounds such as Larazotide act directly as tight junction regulators by blocking zonulin receptors, whereas VIP (Vasoactive Intestinal Peptide) modulates immune responses through G-protein coupled receptors (VPAC1/VPAC2). While each of these molecules targets epithelial homeostasis, KPV provides a distinct, highly localized anti-inflammatory response driven by its small tripeptide structure. Combining or comparing these agents within multi-arm in vitro studies allows investigators to delineate distinct regulatory mechanisms in mucosal immunity.
The Critical Role of USA Synthesis and Endotoxin Clearance
In cellular and immunological research, subtle contaminants can severely distort scientific data. Bacterial endotoxins (lipopolysaccharides, or LPS) present in poorly processed peptide reagents act as potent NF-κB agonists. If a laboratory utilizes KPV contaminated with endotoxins to study NF-κB suppression, the assay will yield false-negative or non-reproducible results, as the LPS contamination actively drives the very inflammatory pathways KPV is meant to attenuate.
PX1 Research enforces strict manufacturing and purification protocols for all USA-synthesized peptides. Every batch of KPV undergoes rigorous purification to achieve a verified purity level exceeding 98% by high-performance liquid chromatography (HPLC). Furthermore, all lots are screened for endotoxin levels in an ISO 17025 accredited laboratory, ensuring levels remain strictly below baseline thresholds (<0.01 EU/mg) suitable for sensitive cell culture and preclinical administration.
Sourcing Risks: PX1 Research vs. Overseas Suppliers
Research laboratories acquiring peptides face significant risks when sourcing from overseas vendors. Unregulated foreign suppliers frequently omit essential quality control steps, leading to sequence errors, truncated peptide side-products, residual TFA (trifluoroacetic acid) salts, and batch-to-batch inconsistency. Additionally, overseas shipments are subject to customs delays, temperature spikes during transit, and dubious Certificate of Analysis (COA) documentation.
PX1 Research eliminates these vulnerabilities by maintaining an end-to-end domestic supply chain. Manufactured in cGMP-compliant facilities within the United States, PX1 KPV comes with independent, third-party lot-specific testing. Orders ship directly from fulfillment centers in California and Arizona with same-day dispatch for orders placed Monday through Friday, guaranteeing chain-of-custody control, chemical stability, and rapid transit times.
Analytical Verification: Interpreting HPLC and Mass Spectrometry Reports
To ensure transparency, PX1 Research provides comprehensive HPLC and Mass Spectrometry (MS) documentation for every lot of KPV available for purchase. Analytical HPLC verifies chemical purity by separating the active tripeptide sequence from synthesis precursors or degradation products, represented as a single, well-defined sharp peak with an integrated area exceeding 98%.
Mass Spectrometry confirms the exact molecular mass of the compound, matching the theoretical mass of KPV (383.48 Da). Together, these analytical techniques confirm that the material received by your facility is structurally identical to the target molecule, completely free of chemical artifacts or incorrect sequences. Investigators can review these verified records directly via our research library before initiating experimental protocols.
Laboratory Reconstitution and Handling Guidelines for KPV
KPV is supplied as a lyophilized (freeze-dried) cake or powder to maximize long-term chemical stability. For optimal shelf-life, unopened vials should be stored at -20°C or -80°C away from light and moisture. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent condensation from forming inside the container.
Reconstitution protocols depend on the specific requirements of the downstream assay. For standard in vitro assays, KPV dissolves readily in sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or cell culture media. Concentrated stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which can induce physical peptide degradation. All handling should adhere to standard aseptic laboratory practices.
Institutional Procurement, Bulk Orders, and Enterprise Supply
Academic institutions, biotechnology firms, and contract research organizations (CROs) often require standardized batch quantities to complete long-term longitudinal studies. Variations between peptide lots mid-study can introduce confounding variables that jeopardize months of research and publication timelines.
PX1 Research accommodates high-volume laboratory requirements through dedicated wholesale accounts. Institutional buyers benefit from reserved single-lot inventory, customized vial sizing, and priority technical support. By partnering with PX1 Research, facilities ensure batch-to-batch uniformity across multi-year experimental series backed by fully verifiable analytical documentation.
Frequently Asked Questions
What is the purity rating of PX1 Research KPV?
PX1 Research guarantees a minimum purity of 98% for KPV, verified via high-performance liquid chromatography (HPLC) and mass spectrometry (MS) for every single production lot.
How does PX1 Research test KPV for endotoxin contamination?
Every lot of KPV undergoes Chromogenic Reagent or LAL endotoxin testing at an independent ISO 17025 accredited laboratory to ensure endotoxin levels remain below 0.01 EU/mg, preventing unwanted immune activation in sensitive cell models.
Where is PX1 KPV synthesized and shipped from?
PX1 KPV is synthesized in cGMP-compliant facilities within the USA. Orders are fulfilled and shipped directly from our logistics facilities in California and Arizona.
How should lyophilized KPV be stored upon arrival?
Lyophilized KPV should be stored at -20°C or -80°C for long-term stability. Avoid exposure to light, heat, and moisture. Reconstituted aliquots should be frozen and kept away from repeated freeze-thaw cycles.
What solvents are recommended for reconstituting KPV in a laboratory?
KPV dissolves easily in sterile water, sterile saline, or standard phosphate-buffered saline (PBS, pH 7.4). For cell culture assays, it can be dissolved directly into sterile culture media.
How does KPV differ structurally from alpha-MSH?
Alpha-MSH is a 13-amino acid neuropeptide, whereas KPV is the tripeptide C-terminal fragment (Lysine-Proline-Valine). KPV retains anti-inflammatory activity through intracellular pathways without binding strongly to melanocortin receptors responsible for pigmentary effects.
Can universities or research institutions set up tax-exempt or bulk orders?
Yes. PX1 Research provides dedicated institutional procurement options, bulk pricing, and lot-reservation services through our wholesale program.
Is KPV supplied by PX1 Research intended for human consumption or medical use?
No. All products sold by PX1 Research, including KPV, are strictly intended for laboratory research use only (in vitro and preclinical models). They are not for human or animal therapeutic, clinical, or diagnostic use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.